Clinical Trial Update: Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen

View source ↗

Summary

A clinical trial update investigating how patient-reported outcome measurements influence outcomes in first-line non-small cell lung cancer treated with chemo-i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: IRCCS San Raffaele | Conditions: PROMs | Status: RECRUITING